The purpose of the study is to determine whether Moxidex ophthalmic solution is safe and
effective in treating marginal corneal infiltrates.
- Diagnosis of marginal corneal infiltrates of size equal to or less than 1.5mm in
diameter, with mild, moderate or severe bulbar conjunctival injection in at least one
- Other protocol-defined inclusion criteria may apply.
- Age related.
- Other protocol-defined exclusion criteria may apply.